Replies to post #134280 on Biotech Values

[jq1234]

If safety translates to quality of life improvement, wouldn't that be a considerable advantage?

It would. But who collects the necessary data to prove the quality of life improvement? Without that, it is very subjective, thus the advantage isn't as big as people say in practice unless the difference is huge.

[NP1986]

If safety translates to quality of life improvement, wouldn't that be a considerable advantage?

It would be, but that message needs to be sold to physicians and IMO that is the difficulty that Aveo/Astellas will face.